Click here to read the articles and download the PDF

Pharmaceutical Commerce - April 2022

Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies

Empowering Patients in Oncology Trials

Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market

Adding Might to ‘Specialty Lite’

The patient-first, pharmacy-first hub model optimizes outcomes and improves care journey for patients with rare disease

Success with SP Solutions

Articles

East Syracuse site will serve as  a hub for company’s US biologics CDMO business

LOTTE to Purchase BMS Manufacturing Facility in New York

Should be administered at least five months after the second dose of the two-dose primary series

Pfizer and BioNTech Granted EUA for Booster Dose of COVID-19 Vaccine in Young Children

Leveraging the value healthcare professionals place on scientific content

Seeing the Value of Scientific Content

Deal establishes company’s presence in Mexico

Procaps Group Acquires Grupo Somar

Prof. Dr. Yvonne Ziegler, is CEO at Mytigate and Full Professor of Business Administration with special focus on Aviation Management at Frankfurt University of Applied Sciences.

Dr. Vincenzo Uli is Product Owner at Mytigate and Research Associate of Business Administration at Frankfurt University of Applied Sciences.

For pharma companies, an investment in a digital risk management tool is worth considering if they want to meet the European Union's regulatory requirements for pharmaceutical transport and wholesalers

Ensuring Compliance and Quality of Pharmaceutical Transport

It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate,  and scale APT supply chains with one single system, the company reports

    HPDC Launches ‘World’s First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies’

Will be investing up to $100 million to expand presence in Taiwan

Bora Pharmaceuticals Acquires Eden Biologics' CDMO Assets

With a $1 billion public commitment, diverse talent and science, space, and VC funding, NYC is emerging as a global capital of life sciences

Featured Content

Pharmaceutical Commerce - April 2022

Empowering Patients in Oncology Trials

Adding Might to ‘Specialty Lite’

Success with SP Solutions